| Literature DB >> 26194097 |
Wei Li1, Yan Chen2, Zhi-Peng Sun3, Zhi-Gang Cai4, Tong-Tong Li5, Lei Zhang6, Min-Xian Huang7, Hong Hua8, Mei Li9, Xia Hong10, Jia-Zeng Su11, Zhu-Yan Zhang12, Yan-Ying Liu13, Jing He14, Zhan-Guo Li15, Yan Gao16, Guang-Yan Yu17.
Abstract
INTRODUCTION: Immunoglobulin G4-related disease (IgG4-RD) is a newly recognized fibro-inflammatory condition. Forty-two cases with immunoglobulin G4-related sialadenitis (IgG4-RS) confirmed by histopathological and immunohistochemical assessment were studied to clarify the clinicopathologic characteristics of the salivary glands involved in IgG4-RS, especially the relationship between the histopathologic features and function of salivary glands or serum levels of IgG4.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26194097 PMCID: PMC4508811 DOI: 10.1186/s13075-015-0698-y
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Fig. 1The inflammation and fibrosis grade of IgG4-RS. a Stage 1: marked diffuse lymphoplasmacytic infiltration. Lymphoid follicles have developed. Fibrosis in the centers of lobules or periductal areas and atrophy of acini (H&E staining, ×100 magnification). b Stage 2: even more prominent lymphoplasmacytic infiltration, with formation of lymphoid follicles with reactive germinal centers, reduction of the parenchyma in the salivary gland, myofibroblast hyperplasia, and storiform fibrosis. Severe fibrosis in lobule centers or periductal areas as well as severe atrophy of acini, but the outline of lobules is retained (H&E, ×100). c Stage 3: destruction of the lobular architecture with marked parenchymal loss and sclerosis, the outlines of lobules are not clear. Germinal centers have degenerated and the light area is obscured (H&E, ×100). H&E hematoxylin and eosin
Fig. 2Enlargement of the sublingual glands (arrows)
Fig. 3Enlargement of the lacrimal (arrowheads) and submandibular glands (arrows)
Quantitative measurements of the volumes of enlarged glands in IgG4-related sialadenitis and normal controls
| Age (years) | Parotid gland | Submandibular gland | Lacrimal gland | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male | Female | Male | Female | Male | Female | |||||||||||||
| Normal ( | IgG4-RS ( |
| Normal ( | IgG4-RS ( |
| Normal ( | IgG4-RS ( |
| Normal ( | IgG4-RS ( |
| Normal ( | IgG4-RS ( |
| Normal ( | IgG4-RS ( |
| |
| 22–44 | 22.187 ± 6.070 | 29.400 ± 0.879 | † | 19.612 ± 4.257 | 28.237 ± 3.119 | † | NS | NS | NS | 7.310 ± 2.282 | 15.034 ± 5.109 | † | 0.432 ± 0.164 | 3.745 ± 21.280 | † | 0.401 ± 0.134 | 2.264 ± 0.526 | † |
| 45–59 | 31.880 ± 9.061 | 42.242 ± 7.227 | † | 21.031 ± 4.033 | 38.061 ± 10.214 | † | 8.637 ± 2.454 | 17.406 ± 4.222 | † | 7.945 ± 1.847 | 14.492 ± 3.866 | † | 0.667 ± 0.217 | 2.103 ± 0.714 | † | 0.624 ± 0.154 | 2.256 ± 1.236 | † |
| ≥60 | NS | NS | NS | 31.846 ± 8.560 | 45.235 ± 8.468 | † | 9.410 ± 3.076 | 14.507 ± 1.562 | † | 7.603 ± 1.678 | 12.037 ± 3.054 | † | 0.549 ± 0.166 | 0.874 ± 0.176 | † | 0.483 ± 0.113 | 1.443 ± 0.828 | † |
Data presented as mean ± standard deviation (cm3)
IgG4-RS IgG4-related sialadenitis, NS not specified
† P <0.01
Fig. 4Bilateral enlargement of the accessory parotid glands (short arrows) and main parotid glands (long arrows) are observed on CT film
Relationship between different parameters and histopathologic grade
| Histopathologic grade | ||||||
|---|---|---|---|---|---|---|
| I | II | III |
| |||
| ( | ( | ( | ||||
| Clinical features | ||||||
| Male/female | 3: 4 | 3: 11 | 1:1 | |||
| Age (years) | 54.1 | 52.0 | 57.4 | 0.539 | ||
| Volumes of swollen salivary glands | PG | 39.65 ± 8.15 | 38.68 ± 10.9 | 34.56 ± 6.03 | 0.223 | |
| SMG | 14.52 ± 2.00 | 16.31 ± 3.40 | 16.23 ± 2.64 | 0.068 | ||
| Serologic examinations | ||||||
| IgG (mg/dl) | 15776.4 ± 6304.9 | 15838.0 ± 3993.0 | 26226.7 ± 9820.8 | 0.001 | ||
| IgG2 (mg/dl) | 539.6 ± 225.3 | 510.8 ± 195.2 | 531.7 ± 221.8 | 0.935 | ||
| IgG4 (mg/dl) | 647.8 ± 700.1 | 818.6 ± 894.1 | 1802.8 ± 1011.0 | 0.002 | ||
| T-IgE (KU/U) | 626.4 ± 705.5 | 361.9 ± 401.8 | 372.2 ± 344.2 | 0.433 | ||
| EOS (%) | 4.7 ± 3.3 | 3.6 ± 3.4 | 4.8 ± 3.6 | 0.638 | ||
| (IgG1 + IgG3) / (IgG2 + IgG4) (%) | 88.3 ± 48.7 | 70.6 ± 23.0 | 47.2 ± 17.5 | 0.007 | ||
| Immunohistochemical examinations | IgG4+ (cells/HPF) | 90 ± 27 | 134 ± 33 | 143 ± 43 | 0.001 | |
| IgG+ (cells/HPF) | 133 ± 37 | 172 ± 37 | 191 ± 42 | 0.001 | ||
| IgG4+/IgG+ (%) | 68.7 ± 12.2 | 78.0 ± 9.8 | 74.0 ± 13.2 | 0.125 | ||
| EOS (cells/HPF) | 23 ± 22 | 17 ± 7 | 11 ± 7 | 0.097 | ||
| Flow rate of whole saliva | Rest (g/5 minutes) | 1.04 ± 0.72 | 1.04 ± 1.27 | 0.82 ± 0.51 | 0.757 | |
| Stimulated (g/5 minutes) | 10.11 ± 3.23 | 8.12 ± 4.24 | 6.78 ± 2.57 | 0.045 | ||
| Scintigraphy | CI (%) | PG | 74.22 ± 9.12 | 77.02 ± 10.77 | 67.26 ± 11.00 | 0.094 |
| SMG | 53.29 ± 12.54 | 49.05 ± 9.10 | 34.20 ± 9.26 | <0.001 | ||
| SI (%) | PG | 47.33 ± 15.10 | 52.14 ± 10.15 | 46.90 ± 14.50 | 0.603 | |
| SMG | 38.50 ± 17.50 | 27.12 ± 9.70 | 26.1 ± 8.50 | 0.055 | ||
CI concentration index, EOS eosinophil, HPF high power field, PG parotid gland, SI secretion index, SMG submandibular gland, T-IgE total immunoglobulin E